Gyros Protein Technologies has been closely monitoring the continuing developments on COVID-19 and travel restrictions/guidance provided by several local and global agencies. As many of our customers have travel bans in place extending for some time and we want to ensure that everyone has a safe and positive experience at the Gyrolab Seminar, we’ve decided to postpone the EU Gyrolab Seminar to later in the year. As more information becomes available we will update you.
This year the Gyrolab Seminar hosts independent speakers from the biotherapeutic industry, presenting the latest papers, applications and advances using Gyrolab nanoliter-scale immunoassay technology. Attendees are a mix of existing users and those who simply wish to find out more about Gyros Protein Technologies and immunoassay advances. Network with others within CRO, CMO, Pharmaceutical, Biotech and Academic organizations.
Application areas discussed:
- Immunogenicity (ADA)
- Pharmacokinetics and toxicokinetics studies
- Impurity testing
- IgG quantification
- Biomarker analysis
- New products presentation